Alliances
Pioneering partners Cmed and Innovative Physics have combined forces to showcase The Real Time Medical Imaging Users Tool Kit®, which uses artificial intelligence to support secure, rapid diagnostics in clinical trials, at DPharm 2018.
CMS gains exclusive rights to current VAXIMM pipeline and option for future programs for China and other Asian countries, ex-Japan
LineaRx, a subsidiary of Applied DNA Sciences, has entered into a Joint Development Agreement with Takis SRL and Evvivax SLR. They will focus on developing anti-cancer vaccines.
Shares of OncoMed Pharmaceuticals are falling this morning after the company announced that Celgene has walked away from a deal to license the company’s bispecific antibody navicixizumab.
Shares of Molecular Templates are up more than 52 percent in premarket trading after the company announced it has struck a deal with pharma giant Takeda Pharmaceuticals.
China’s Hillhouse Capital Group, an equity investment firm, has a new fund, Hillhouse Fund IV, with $10.6 billion ready to invest.
Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach
Poietis and Prometheus, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.
Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dating back to 1749.
LEO Pharma A/S and MorphoSys AG today announced an expansion of their existing strategic alliance to include peptide-derived therapeutics.
PRESS RELEASES